Abrdn PLC Abcam PLC Transaction History

Abrdn PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$21.54 - $24.41 $6,892 - $7,811	-320 Reduced 0.78%	40,603 $918,000
Q2 2023 Jun 20, 2024	SELL	$12.62 - $24.47 $6,310 - $12,235	-500 Reduced 1.21%	40,923 $1 Million
Q2 2023 Aug 04, 2023	SELL	$12.62 - $24.47 $6,310 - $12,235	-500 Reduced 1.21%	40,923 $1 Million
Q1 2023 Jun 20, 2024	SELL	$12.98 - $17.1 $11.9 Million - $15.6 Million	-913,477 Reduced 95.66%	41,423 $557,000
Q1 2023 Apr 28, 2023	SELL	$12.98 - $17.1 $11.9 Million - $15.6 Million	-913,477 Reduced 95.66%	41,423 $557,000
Q4 2022 Jun 20, 2024	BUY	$13.92 - $17.0 $13.3 Million - $16.2 Million	954,900 New	954,900 $14.9 Million
Q4 2022 Feb 09, 2023	BUY	$13.92 - $17.0 $13.3 Million - $16.2 Million	954,900 New	954,900 $14.9 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

Stay updated on Abrdn PLC with notifications on news.